The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007

Similar Items

• The adequacy of FDA to assure the safety of the nation's drug supply : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007.
  Published: (2007)
• FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet meets standards for safety and efficacy, March 1, 2005.
  Published: (2005)
• FDA proposals to ease restrictions on the use and sale of experimental drugs : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, April 29, 1987.
  Published: (1987)
• FDA proposals to ease restrictions on the use and sale of experimental drugs : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One hundredth Congress, first session, April 29, 1987
  Published: (1987)
• Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992
  Published: (1993)